Conversely, stimulation of AT1a by exogenous application of Ang II, at a dose that does not affect blood pressure (subpressor dose), significantly exacerbated cardiac hypertrophy and dramatically augmented interstitial fibrosis in GC-A-KO mice, but not in wild-type animals. The gene discussed is GCA; the disease is cardiac hypertrophy.